Section Menu  


How to Obtain Authorized User Status

Posted: August 9, 2023

In 2022, the American Board of Radiology announced that it was terminating the Nuclear Regulatory Commission recognition of all ABR certification processes after December 31, 2023. This change is important for radiation oncologists that want to begin offering radiopharmaceuticals but have not previously offered treatments regulated by the NRC, such as brachytherapy or radiopharmaceutical therapy.

ASTRO Engages RPT Stakeholders

Posted: June 13, 2023

Learn more about ASTRO's recent activities regarding radiopharmaceutical therapies from John Buatti, MD, FASTRO, vice-chair of the ASTRO Science Council and chair of the RPT Work Group.

How to Become a Licensee or an Authorized User for Radiopharmaceuticals

Posted: April 26, 2022

Is your practice interested in becoming licensed to use radiopharmaceuticals? Or, are you interested in becoming an authorized user to administer radiopharmaceuticals? With new radiopharmaceuticals gaining approval from the U.S Food and Drug Administration and more in the pipeline, now is a good time to understand some practical steps to take.

Copyright © 2024 American Society for Radiation Oncology